Risk-based serological survey of bluetongue and the first evidence of bluetongue virus serotype 26 circulation in Tunisia.

BACKGROUND: Bluetongue (BT), a vector-borne disease of wild and domestic ruminants, is responsible for severe economic losses in flocks. To reduce this impact, a surveillance and control plan was implemented in Tunisia. However, the epidemiological situation of BT remains incompletely understood, especially for the circulating serotypes. OBJECTIVE: The aim of this survey was to determine the seroprevalence, to identify the circulating serotypes and to identify the associated risk factors for bluetongue virus (BTV) circulation in Tunisia using risk-based sampling (RBS). METHODS: A total of 3314 blood samples were randomly collected from 67 sectors using risk-based sampling and screened by competitive enzyme-linked immunosorbent assays (c-ELISAs). Out of the 1330 positive samples, 200 samples were analysed by serum neutralization test (SNT) to identify circulating BTV serotypes. RESULTS: Of 3314 sera, 1330 were c-ELISA-positive (40.1%) for antibodies against the BTV structural protein VP7. The result of SNT showed the presence of BTV-1, BTV-2, BTV-3, BTV-4 and, for the first time in Tunisia, BTV-26. The logistic regression model revealed that older animals had nearly two times the odds of being infected with BTV compared to younger animals. Flocks with a history of BT were almost 1.5 times more likely to be at risk for contracting BTV infection. The flock size, housing indoors and intensive production system were significant protective factors. CONCLUSIONS: High seroprevalence of BTV among sheep was highlighted in Tunisia. The neutralization test showed the presence of the following BTV serotypes: BTV-1, BTV-2, BTV-3, BTV-4 and, for the first time in Tunisia, BTV-26. Age, production system and flock size were important variables associated with BTV infection in sheep. This finding is crucial, as it will allow the adjustment of the BT control programme in Tunisia.

Hiding in plain sight-wildlife as a neglected reservoir and pathway for the spread of antimicrobial resistance: a narrative review.

Antimicrobial resistance represents a global health problem, with infections due to pathogenic antimicrobial resistant bacteria (ARB) predicted to be the most frequent cause of human mortality by 2050. The phenomenon of antimicrobial resistance has spread to and across all ecological niches, and particularly in livestock used for food production with antimicrobials consumed in high volumes. Similarly, hospitals and other healthcare facilities are recognized as significant 'hotspots' of ARB and antimicrobial resistance genes (ARGs); however, over the past decade, new and previously overlooked ecological niches are emerging as hidden reservoirs of ARB/ARGs. Increasingly extensive and intensive industrial activities, degradation of natural environments, burgeoning food requirements, urbanization, and global climatic change have all dramatically affected the evolution and proliferation of ARB/ARGs, which now stand at extremely concerning ecological levels. While antimicrobial resistant bacteria and genes as they originate and emanate from livestock and human hosts have been extensively studied over the past 30 years, numerous ecological niches have received considerably less attention. In the current descriptive review, the authors have sought to highlight the importance of wildlife as sources/reservoirs, pathways and receptors of ARB/ARGs in the environment, thus paving the way for future primary research in these areas.

Low antibiotic resistance rates and high genetic heterogeneity of Escherichia coli isolates from urinary tract infections of diabetic patients in Tunisia.

Antimicrobial resistance phenotypes, tetracycline, sulphonamide resistance genes, and integrons were analysed in 48 Escherichia coli isolates recovered from urine cultures of diabetic patients in Tunisia. Twenty-one were susceptible to all antibiotics tested. High rates of resistance were observed for amoxicillin (39.5%), trimethoprim-sulphamethoxazole (33.3%), sulphonamide (33.3%), and tetracycline (31.2%). Resistance to imipenem was not detected, and ESBL producing isolates were not recovered. Our analysis assigned 26, 13, 3, and 5 isolates to phylogroups A, B1, B2, and D, respectively. It is worthy to note that all the resistant isolates belonged to phylogroups A (15 isolates) and B1 (12 isolates), while for the 21 susceptible isolates, phylogroups A, B1, B2, and D were found in 11, 2, 3, and 5 isolates, respectively. Among 15 tetracycline-resistant isolates, the tetA and tetB genes were detected in three and four isolates, respectively. Among 17 sulphonamide resistant isolates, 12, 3, and 1 isolates harboured sul1, sul2, and sul3, respectively. sul1 and sul2 genes occurred simultaneously in three isolates. Integrons were detected in 11 isolates. Ten isolates harboured the class 1 integron and three the class 2 integron. The variable regions (VRs) of the class 1 integrons were analysed in the 10 in1-positive isolates, and the following gene cassette arrangements were detected: dfrA12-orfF-aadA2-cmIA1-aadA1-qacH-IS440-sul3 (one isolate), dfrA15-aadA1 (three isolates), dfrA5 (one isolate), dfrA17- aadA5 (one isolate), dfrA1-aadA1 (one isolate), and dfrA14 (one isolate). The VR of class 2 integron was analysed in the in2-positive isolates, and only one gene cassette arrangement was detected, dfrA1-sat-aadA1. Pulsed-field gel electrophoresis (PFGE) analysis of resistant isolates showed that all were unrelated. Our results highlight the moderate antibiotic resistance in the clinical isolates as well as their heterogeneous genetic background.